Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
URGN —
UROGEN PHARMA LTD
CUSIP: M96088105 · Held by 2 superinvestors · Combined value: $24,976,423
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $19,254,917 | 822,157 | ADD | +37,780 |
| 2 | Jim Simons | 0.0% | $5,721,506 | 244,300 | REDUCE | -30,800 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +37,780 | +4.8% |
| Jim Simons | REDUCE | -30,800 | -11.2% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +236,900 | +620.2% |
| Ken Griffin | REDUCE | -210,119 | -21.1% |
Who Owns URGN? Superinvestor Holdings
UROGEN PHARMA LTD is held by 2 tracked superinvestors, with a combined position value of $25 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Jim Simons (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions while 1 reduced or exited.